Cyclooxygenase as a target in chemoprevention by probiotics during 1,2-dimethylhydrazine induced colon carcinogenesis in rats

Nutrition and Cancer

Volumn 67, Issue 4, 2015, Pages 603-611

  Walia, Sohini ^a   Kamal, Rozy ^b   Kanwar, Sarbjit Singh ^a   Dhawan, Davinder Kumar ^b  

^a CSK HIMACHAL PRADESH AGRICULTURAL UNIVERSITY   (India)

^b PANJAB UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 DIMETHYLHYDRAZINE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; PROBIOTIC AGENT; SIALIC ACID; MEMBRANE PROTEIN; N ACETYLNEURAMINIC ACID; PTGS1 PROTEIN, RAT; PTGS2 PROTEIN, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INCIDENCE; CANCER PREVENTION; CANCER SIZE; CELL PROLIFERATION; CHEMOPROPHYLAXIS; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; LACTOBACILLUS PLANTARUM; LACTOBACILLUS RHAMNOSUS; NONHUMAN; PROTEIN EXPRESSION; RAT; WEIGHT CHANGE; ANIMAL; BLOOD; BODY WEIGHT; CHEMICALLY INDUCED; COLONIC NEOPLASMS; DOWN REGULATION; GENETICS; METABOLISM; SPRAGUE DAWLEY RAT;

LACTOBACILLUS PLANTARUM; LACTOBACILLUS RHAMNOSUS; RATTUS;

1,2-DIMETHYLHYDRAZINE; ANIMALS; BODY WEIGHT; CHEMOPREVENTION; COLONIC NEOPLASMS; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DOWN-REGULATION; FEMALE; LACTOBACILLUS PLANTARUM; LACTOBACILLUS RHAMNOSUS; MEMBRANE PROTEINS; N-ACETYLNEURAMINIC ACID; PROBIOTICS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84929128330     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2015.1011788     Document Type: Article

References (55)

1. Fuller R: Probiotics in man and animals. J Appl Bacteriol 66, 365-378, 1989.
2. Ouwehand AC and Salminen SJ: The health effects of cultured milk products with viable and non-viable bacteria. Int Dairy J 8, 749-758, 1998.
3. Felis G and Dellaglio F: Taxonomy of Lactobacilli and Bifidobacteria. Curr Issues Intest Microbiol 8, 44-61, 2007.
4. Weiss KA, Christiaansen AF, Fulton RB, Meyerholz DK, and Varga SM: Multiple CD4C T cell subsets produce immunomodulatory IL-10 during respiratory syncitial virus infection. J Immunol 187, 3145-3154, 2011.
5. Kailasapathy K and Chin J: Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacteria spp. Immunol Cell Biol 78, 80-88, 2000.
6. Kullisaar T, Zilmer M, Mikelsaar M, Vihalemm T, Annuk H, et al.: Two antioxidative Lactobacilli strains as promising probiotics. Int J Food Microbiol 72, 215-224, 2002.
7. Chan ES and Zhang Z: Bioencapsulation by compression coating of probiotic bacteria for their protection in an acidic medium. Process Biochem 40, 3346-3351, 2005.
8. Wagar LE, Champagne CP, Buckley ND, Raymond Y, and Green-Johnson JM: Immunomodulatory properties of fermented soy and dairy milks prepared with lactic acid bacteria. J Food Sci 74, 23-30, 2009.
9. Foligne B, Dewulf J, Breton J, Claisse O, and Lonvaud-Funel A: Probiotic properties of non-conventional lactic acid bacteria: immunomodulation by Oenococcus oeni. Int J Food Microbiol 15, 136-145, 2010.
10. Todorov SD, LeBlanc JG, and Bernadette DGMF: Evaluation of the probiotic potential and effect of encapsulation on survival for Lactobacillus plantarum ST16Pa isolated from papaya. World J Microb Biot 28, 973-984, 2012.
11. Bray F, Jemal A, Grey N, Ferlay J, and Forman D: Global cancer transitions according to the Human Development Index (2008-2030): A population-based study. The Lancet Oncol 13, 790-801, 2012.
12. Sivieri K, Spinardi-Barbisan ALT, barbisan LF, Bedani R, Pauly ND, et al.: Probiotic Enterococcus faecium CRL 183 inhibit chemically induced colon cancer in male Wistar rats. Eur Food Res Technol 228, 231-237, 2008.
13. Goldin BR and Gorbach SL: Effect of Lactobacillus acidophilus dietary supplements on 1,2-dimethylhydrazine dihydrochloride-induced intestinal cancer in rats. J Natl Cancer Inst 64, 263-265, 1980.
14. Goldin BR, Gualtieri LJ, and Moore RP: The effect of Lactobacillus GG on the initiation and promotion of DMH-induced intestinal tumors in the rat. Nutr Cancer 25, 197-204, 1996.
15. Walia S, Keshani, Sood S, and Kanwar SS: Exhibition of DNA-bioprotective activity by microflora of traditional fermented foods of North-Western Himalayas. Food Res Int 55, 176-180, 2014.
16. Hosomi Y, Yokose T, Hirose Y, Nakajima R, Nagai K, et al.: Increased cyclooxygenase 2 (COX-2) expression occurs frequently in precursor lesions of human adenocarcinoma of the lung. Lung Cancer 30, 73-81, 2000.
17. Anderson WF, Umar A, Viner JL, and Hawk ET: The role of cyclooxygenase inhibitors in cancer prevention. Curr Pharm Des 8, 1035-1062, 2002.
18. Fang HY, Lin TS, Lin JP, Wu YC, Chow KC, et al.: Cyclooxygenase-2 in human non-small cell lung cancer. Eu J Surg Oncol 2, 171-177, 2003.
19. Plummer SM, Holloway KA, Manson MM, Munks RJ, Kaptein A, et al.: Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex. Oncogene 18, 6013-6020, 1999.
20. Saini MK, Vaiphei K, and Sanyal SN: Chemoprevention of DMHinduced rat colon carcinoma initiation by combination administration of piroxicam and C-phycocyanin. Mol Cell Biochem 361, 217-228, 2012.
21. Putaala H, Salusjarvi T, Nordstrom M, Saarinen M and Ouwehand AC, et al.: Effect of four probiotic strains and Escherichia coli O157:H7 on tight junction integrity and cyclo-oxygenase expression. Res Microbiol 159, 692-698, 2008.
22. Nurmi JT, Puolakkainen PA, and Rautonen NE: Bifidobacterium lactis sp. 420 up-regulates cyclooxygenase (Cox)-1 and down-regulates Cox-2 gene expression in a caco-2 cell culture model. Nutr Cancer 51, 83-92, 2005.
23. Sourabh A, Kanwar SS, and Sharma PN: Diversity of bacterial probiotics in traditional fermented foods of Western Himalayas. Int J Probiotics Prebiotics 5, 193-202, 2010.
24. Dani V, Goel A, Vaiphei K, and Dhawan DK: Chemopreventive potential of zinc in experimentally induced colon carcinogenesis. Toxicol Lett 171, 10-18, 2007.
25. Katopodis N and Stock CC: Improved method to determine lipid bound sialic acid in plasma or serum. Res Commun Chem Pathol Pharmacol 30, 171-180, 1980.
26. Bradford MM: A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding. Anal Biochem 72, 248-254, 1976.
27. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685, 1970.
28. Freeman HJ, Kim Y, and Kim YS: Glycoprotein metabolism in normal proximal and distal rat colon and changes associated with 1,2-dimethylhydrazine-induced colonic neoplasia. Cancer Res 38, 3385-3390, 1978.
29. Srihari T, Sengottuvelan M, and Nalini N: Dose-dependent effect of oregano (Origanum vulgare L.) on lipid peroxidation and status in 1,2-dimethylhydrazine-induced rat colon carcinogenesis. J Pharm Pharmacol 60, 787-794, 2008.
30. Femia AP and Caderni G: Rodent models of colon carcinogenesis for the study of chemopreventive activity of natural products. Planta Med 74, 1602-1607, 2008.
31. Shirai T, Nakanowatari J, Kurata Y, Fukushima S, and Ito N: Different dose-response relationships in the induction of different types of colonic tumors in Wistar rats by 1,2-dimethylhydrazine. Gann 74, 21-27, 1983.
32. Swenberg JA, Cooper HK, Bucheler J, and Kleihues P: 1,2 Dimethylhydrazine induced methylation of DNA bases in various rat organs and the effects of pre-treatment with disulfiram. Cancer Res 39, 465-467, 1979.
33. Gennaro AR, Villanueva R, Sukonthaman Y, Vathanophas V, and Rosemond GP: Chemical carcinogenesis in transported intestinal segments. Cancer Res 33, 536-541, 1973.
34. Li W and Li CB: Effect of oral Lactococcus lactis containing endostatin on 1,2-dimethylhydrazine-induced colon tumor in rats. World J Gastroenterol 11, 7242-7247, 2005.
35. Lee SM and Lee WK: Inhibitory Effects of Lactic Acid Bacteria (LAB) on the azoxymethane-induced colonic preneoplastic lesions. The J Microbiol 38, 169-175, 2000.
36. Albuquerque G, Redondo P, and Nakamura CV: Differential expression of sialic acid and N-acetylgalactosamine residues on the cell surface of intestinal epithelial cells according to normal or metastatic potential. J Histochem Cytochem 52, 629-640, 2004.
37. Miyazaki K, Ohmori K and Izawa M: Loss of disialyl Lewis(a), the ligand for lymphocute inhibitory receptor sialic acid-binding immunoglobulin like lectin-7 (Siglec-7) associated with increased sialyl Lewis (a) expression on human colon cancers. Cancer Res 64, 4498-4505, 2004.
38. Morotomi M and Mutai M: In vitro binding of potent mutagenic pyrolysates. J Natl Cancer Inst 77, 195-201, 1986.
39. Tanabe T, Otani H, and Hosono A: Binding of mutagens with cell wall peptidoglycan of Leuconostocmesenteroides subsp. dextranicum T-180. Milchwissen-Schaft 46, 622-625, 1991.
40. Rajendran R and Ohta Y: Binding heterocyclic amines by lactic acid bacteria from miso, a fermented Japanese food. Can J Microbiol 44, 109-115, 1998.
41. Veceric Z and Cerar A: Comparison of Wistar vs. Fischer rat in the incidence of 1,2-dimethylhydrazine induced intestinal tumors. Radiol Oncol 38, 227-234, 2004.
42. Singh J, Rivenson A, Tomita M, Shimamura S, Ishibashi N, et al.: Bifidobacterium longum, a lactic acid-producing intestinal bacterium inhibits colon cancer and modulates the intermediate biomarkers of colon carcinogenesis. Carcinogenesis 18, 833-841, 1997.
43. Kumar RS, Kanmani P, Yuvaraj N, Paari KA, Pattukumar V, et al.: Lactobacillus plantarum AS1 isolated from south Indian fermented food Kallappam suppress 1,2-dimethyl hydrazine (DMH)-induced colorectal cancer in male Wistar rats. Appl Biochem Biotechnol 166, 620-631, 2012.
44. LeBlanc JG, de Moreno de Leblanc ADM, Perdigon G, Anderson M, Tatiana R, et al.: Anti-inflammatory properties of lactic acid bacteria: current knowledge, applications and prospects. Antiinfect Agents Med Chem 7, 148-154, 2008.
45. Tammali R, Ramana KV, Singhal SS, Awasthi S, and Srivastava SK: Aldose reductase regulates growth factor-induced cyclooxygenase-2 expression and prostaglandin E2 production in human colon cancer cells. Cancer Res 66, 9705-9713, 2006.
46. Sarkar FH, Adsule S, Li Y, and Padhye S: Back to future: COX-2 inhibitors for chemoprevention and cancer therapy. Mini-Rev Med Chem 7, 599-608, 2007.
47. Hold GL and El-Omar EM: Genetic aspects of inflammation and cancer. Biochem J 410, 225-235, 2008.
48. Sobolewski C, Cerella C, Dicato M, Ghibelli L, and Diederich M: The role of cyclooxygenase-2 in cell proliferation and cell death in human malignancies. Int J Cell Biol 2010, 1-21, 2010. doi:10.1155/2010/215158
49. Carlson ML, Wilson ET, and Prescott SM: Regulation of COX-2 transcription in a colon cancer cell line by Pontin52/TIP49a. Molecular Cancer 2, 42, 2003.
50. Luu HH, Zhang R, Haydon RC, Rayburn E, Kang Q, et al.: Wnt/beta-catenin signaling pathway as a novel cancer drug target. Curr Cancer Drug Tar 4, 653-671, 2004.
51. Lee HY, Crawley S, Hokari R, Kwon S, and Kim YS: Bile acid regulates MUC2 transcription in colon cancer cells via positive EGFR/PKC/Ras/ERK/ CREB, PI3K/Akt/IkappaB/NF-kappaB and p38/MSK1/CREB pathways and negative JNK/c-Jun/AP-1 pathway. Int J Oncol 36, 941-953, 2010.
52. Wang TP, Hsu SH, Feng HC, and Huang RF: Folate deprivation enhances invasiveness of human colon cancer cells mediated by activation of sonic hedgehog signaling through promoter hypomethylation and cross action with transcription nuclear factor-kappa B pathway. Carcinogenesis 33, 1158-1168, 2012.
53. Bassaganya-Riera J, Viladomiu M, Pedragosa M, De Simone C, and Hontecillas R: Immunoregulatory mechanisms underlying prevention of colitis-associated colorectal cancer by probiotic bacteria. PLoS One 7, e34676, 2012.
54. Otte JM, Mahjurian-Namari R, Brand S, Werner I, Schmidt WE, et al.: Probiotics regulate the expression of COX-2 in intestinal epithelial cells. Nutr Cancer 61, 103-113, 2009.
55. Srinivasan BD and Kulkarni PS: Inhibitors of the arachidonic acid cascade in the management of ocular inflammation. Prog Clin Biol Res 312, 229-249, 1989.